Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension
Condition(s) studied
Investigational drug(s) / intervention(s)
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg: PO, Once daily(QD), 8 weeks and 26 weeks if applicable
Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg: PO, Once daily(QD), 8 weeks and 26 weeks if applicable
Study summary
This study is to compare the efficacy and safety of Telmisartan, Amlodipine, and Chlorthalidone Fixed-Dose Combination and Telmisartan, Amlodipine, and Hydrochlorothiazide in Elderly Patients with Essential Hypertension Uncontrolled by Telmisartan and Amlodipine Combinations
Eligibility
Primary outcome measure(s)
- Mean Systolic Blood Pressure (MSBP) in nighttime — Week 8
To evaluate change from baseline in nighttime Mean Systolic Blood Pressure (MSBP) measured by Ambulatory Blood Pressure Monitoring at Week 8
Trial sites (15)
| Facility | City | Region | Status |
|---|---|---|---|
| Wonju Severance Christian Hospital | Wŏnju | Gangwon-do | |
| The Catholic University of Korea Bucheon St.Mary's Hospital | Seoul | Gyeonggi-do | |
| Pusan National University Yangsan Hospital | Busan | South Korea | |
| The Catholic University of Korea Daejeon ST. Mary's Hospital | Daejeon | South Korea | |
| Chonnam National University Hospital | Gwangju | South Korea | |
| Gwangju Veterans Hospital | Gwangju | South Korea | |
| The Catholic University of Korea, ST. Vincent's Hospital | Gyeonggi-do | South Korea | |
| The Catholic University of Korea, Incheon ST. Mary's Hospital | Incheon | South Korea | |
| The Catholic University of Korea, Eunpyeong St. Mary's Hospital | Seoul | South Korea | |
| Hanyang university medical center | Seoul | South Korea | |
| The Catholic University of Korea, Seoul ST. Mary's Hospital | Seoul | South Korea | |
| The Catholic University of Korea, Yeouido ST. Mary's Hospital | Seoul | South Korea | |
| Korea University Guro Hospital | Seoul | South Korea | |
| The Catholic University of Korea, Uijeongbu ST. Mary's Hospital | Seoul | South Korea | |
| Seoul national University Budang hospital | Seoul | South Korea |
More Yuhan Corporation trials in South Korea
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06041529 on ClinicalTrials.gov ↗ ← All trials in South Korea